# FDA Inspection 1028861 - Sightlife - October 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/sightlife/b7c48c7a-0299-4259-84d9-154fc5f94dd2
Source feed: FDA_Inspections

> FDA Inspection 1028861 for Sightlife on October 13, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028861
- Company Name: Sightlife
- Inspection Date: 2017-10-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1254770 - 2024-11-18](https://www.keypedia.com/records/fda_inspections/sightlife/0db641ea-ade3-43dc-991c-23c345073e93)
- [FDA Inspection 1254770 - 2024-11-18](https://www.keypedia.com/records/fda_inspections/sightlife/670106ee-d087-41d9-a56f-0fd36308f793)
- [FDA Inspection 1198187 - 2023-02-10](https://www.keypedia.com/records/fda_inspections/sightlife/97f29f8f-c434-4d21-b667-7dbfd8633440)
- [FDA Inspection 1198187 - 2023-02-10](https://www.keypedia.com/records/fda_inspections/sightlife/4fd8dc5e-b8ad-4f8c-b55e-7d16397a6059)
- [FDA Inspection 1198187 - 2023-02-10](https://www.keypedia.com/records/fda_inspections/sightlife/cb8274d1-b7e5-43d5-bb5f-9955e8be01d4)

Company: https://www.keypedia.com/companies/sightlife/7bfeee4c-fe3f-4f4d-8837-5845b36d913c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d